Related Experiment Video
Updated: Mar 19, 2026
06:39
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
Published on: October 27, 2023
1.6K
Curcumin: A new candidate for melanoma therapy?
Hamed Mirzaei1, Gholamreza Naseri2, Ramin Rezaee3
1Department of Medical Biotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
International Journal of Cancer
|June 10, 2016
Summary
Curcumin, a natural compound, shows promise against melanoma by inhibiting tumor growth and spread. Enhanced delivery systems improve its bioavailability, potentially leading to new melanoma treatments.
Area of Science:
- Oncology
- Pharmacology
- Natural Products Chemistry
Background:
- Melanoma is a lethal cancer with limited treatment options for metastatic disease.
- Herbal remedies offer therapeutic potential but can have adverse effects.
- Curcumin, a phytochemical, exhibits anti-cancer properties with minimal side effects.
Purpose of the Study:
- To review the anti-melanoma effects of curcumin.
- To explore novel curcumin formulations and delivery systems for enhanced bioavailability.
- To assess curcumin's potential as a therapeutic agent for melanoma.
Main Methods:
- Literature review of in vitro and in vivo studies on curcumin and melanoma.
- Analysis of curcumin's molecular and cellular mechanisms against melanoma.
- Evaluation of advanced delivery systems (nanoparticles, liposomes, etc.) for curcumin.
Main Results:
- Curcumin demonstrates anti-angiogenic, pro-apoptotic, and immunomodulatory effects relevant to melanoma.
- It targets key pathways in melanoma initiation and progression.
- New formulations significantly enhance curcumin's bioavailability.
Conclusions:
- Curcumin exhibits significant anti-melanoma potential.
- Enhanced bioavailability through novel delivery systems is crucial for therapeutic efficacy.
- Further clinical investigation of tailored curcumin formulations is warranted for melanoma treatment.
Related Concept Videos
01:30Skin Cancer
6.5K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K